2012, Number 2
<< Back Next >>
Enf Infec Microbiol 2012; 32 (2)
Vaginal colonization with Streptococcus agalactiae in women with cervical dysplasia
López GA, Ruiz TA, Rodríguez PR, Mauleón MA, Rivera TJA
Language: Spanish
References: 22
Page: 61-68
PDF size: 515.78 Kb.
ABSTRACT
Cervical cancer is a reproductive health problem in women, ranking third among cancers, remains the leading cause of cancer death among women in developing countries. Vaginal infection by microorganisms is commonly found in the adolescent period and reproductive age.
Objective. To study the prevalence of
Streptococcus agalactiae in women with cervical dysplasia.
Methods. The study included 200 patients with cervical dysplasia, aged 17 to 80 years old. Vaginal culture was performed, and in the case of vaginal swab samples were taken three, placing them in sterile saline solution, Stuart transport and Streptocel media for processing in the laboratory. The tube with saline solution used to make a fresh examination, Stuart medium was inoculated into enrichment, selective and differential media for the identification of microorganisms that were isolated. Once the broth Streptocel was incubated for 24 hours at 37° C, were inoculated on ram blood agar plate which was incubated at 37° C for 24 hours.
Results. The prevalence of cervical dysplasia was higher in the age group 33 to 40 years 32.4%. Of the 200 vaginal swabs in 83 (41.5%) had isolated some microorganisms of medical importance of these in 60 (30%) identified the presence of a single organism, and in 23 (11.5%) cases were isolated more of an etiologic agent.
Streptococcus agalactiae was isolated in 5.5% of the cases studied.
Conclusion. The frequency of
S. agalactiae is similar to the general population in Mexico.
REFERENCES
Celis AM, Aldas GJ, Toro MFA. “Estudio de cohorte sobre el impacto del diagnostico de displasia cervical e infección por virus del papiloma humano en la función sexual de mujeres en un hospital de segundo nivel en Bogotá, Colombia”. RCOG 2010; 61:303-309.
Salas UI, Villalobos EA, Ramírez VBL. “Prevalencia de displasia y cáncer cervicouterino y factores asociados en el Hospital Central de Chihuahua, México”. CIMEL. 2006; 11:12-15.
Meyn LA, Moore DM, Hillier SL, Krohn MA. “Association of sexual activity with colonization and vaginal acquisition of group B Streptococcus in nonpregnant women”. Am J Epidemiol 2002; 155:949-957.
Lopéz CA, Alvarez MJ, Murillo LJ. “Cáncer cervicouterino, epidemiología y su relación con los factores de riesgo”. Arch. Salud Sin 2010; 4:9-13.
Martino JL, Vermund SH. “Vaginal douching: evidence for risk or benefits to women´s health”. Epidemiol Rev 2002; 24:109-124.
Cherpes TL, Melan MA, Kant JA, Copsentino LA, Meyn LA, Hillier SL. “Genital tract shedding of Herpes simplex virus type 2 in women: effects of hormonal contraception, bacterial vaginosis, and vaginal group B Streptococcus colonization”. Clin Infect Dis 2005; 40:1422-1428.
Bolduc GR, Madoff LC. “The group B streptococcal alpha C protein binds α1ß1-integrin through a novel KTD motif that promotes internalization of GBS within human epithelial cells”. Microbiology 2007; 153:4039-4049.
Muñoz G, Gómez C, Sánchez J. “Displasias cervicales asociadas a agentes patógenos”. Sociedad Científica de Estudiantes de Medicina de la UCV. 2009; 13: 244-248.
Park S, Kelley KA, Vinogradov E, Solinga R, Weidenmaier C, Misawa Y, Lee JC. 2010. “Characterization of the structure and biological functions of a capsular polysaccharide produced by Staphylococcus saprophyticus”. J Bacteriol 2010; 192:4618-4626.
Committee on Infectious Diseases and Committe on Fetus and Newborn (CIDCFN). Revised guidelines for prevention of early-onset group B Streptococcal (GBS) infection. Pediatrics 1997; 99:489-496.
Walker S. Microbiología. McGraw-Hill Interamericana. 1ª edición. 2001; 126-128.
Johri AK, Margarit I, Broenstrup M, Brettoni C, Hua L, Gygi SP, Telford JL, Grandi G, Paoletti LC. “Transcriptional and proteomic profiles of group B Streptococcus type V reveal potential adherence proteins associated with high-level invasion”. Infect Immun 2007; 75:1473-1483.
García SD, Cora M, Lazzo M, Copolillo E, Barata A, de Torres R. “Portación de estreptococo grupo B en mujeres embarazadas”. Rev Arg Microbiología 2003; 32: 183-187.
Puopolo KM. “Epidemiology of neonatal early-onset sepsis”. NeoReviews 2008; 9:e571-e579.
Diedrick MJ, Flores AE, Hillier SL, Creti R, Ferrieri P. “Clonal analysis of colonizing group B Streptococcus, serotype IV, an emerging pathogen in the United States”. J Clin Microbiol 2010; 48:3100-3104.
Puopolo KM, Madoff LC. “Type IV neonatal early-onset group B Streptococcal disease in a United States hospital”. J Clin Microbiol 2007; 45:1360-1362.
Flores R, Rivera R, García E, Arriaga M. “Etiología de la infección cérvico vaginal en pacientes del Hospital Juárez de México”. Salud Pública Mex. 2003; 45: 694-697.
Flores C, Vidal O, Saldívar D, Núñez R. “Prevalencia de displasia cervical en embarazadas en el Hospital Universitario de Monterrey, Nuevo León. México”. Revista Chilena de Obstetricia y Ginecología 2010; 75:290-293.
Alaniz A, Flores J, Salazar C. “Factores de riesgo para el desarrollo de la displasia leve cervical. México”. Revista Facultad de Medicina de la UNAM. 2009; 52:70-72.
León G, Bosques O. “Infección por el virus del papiloma humano y factores relacionados con la actividad sexual en la génesis del cáncer de cuello uterino”. Revista Cubana Obstétrica Ginecológica 2005; 31:43-47.
Di Bartolomeo S, Rodríguez M, Sauka D, Torres M. “Prevalencia de microorganismos asociados a secreción genital femenina”. Revista Argentina de Salud Pública 2002; 36:84-85.
Sánchez M, Uribe F, Conde C. “La infección por el virus del papiloma humano, un posible marcador biológico de comportamiento sexual en estudiantes universitarios”. Revista Salud Pública Mex 2002; 44:442-447.